Translational Drug Development (TD2)
Chief Medical Officer
Paula M. Fracasso, MD, PhD, LLC
Principal, Oncology Drug Development Consultancy
Virginia Commonwealth University
Professor of Medicine and Obstetrics and Gynecology
University of Virginia
Penniston Family Professor of Women's Oncology
University of Virginia
Section Chief, Medical Oncology
University of Virginia
Visiting Professor of Medicine and Obstetrics and Gynecology
VCU Massey Cancer Center
Deputy Director and SVP, Cancer Service LIne
Adaptimmune US
Vice President and Head, Clinical Development
Adaptimmune US
Consultant to the Chief Medical Officer
University of Virginia
Deputy Director, UVA Cancer Center
Yale University
College of the Holy Cross
Yale University School of Medicine
